+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Shingles Vaccine Market 2020-2024 - Product Image

Global Shingles Vaccine Market 2020-2024

  • ID: 5005610
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • CanSino Biologics Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • SK Bioscience
  • MORE
Global Shingles Vaccine Market 2020-2024.

The publisher has been monitoring the global shingles vaccine market 2020-2024 and it is poised to grow by USD 1.08 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. The report on the global shingles vaccine market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by approval of shingles vaccines and favorable reimbursement policies. In addition, high incidence and prevalence of shingles is anticipated to boost the growth of the global shingles vaccine market 2020-2024 as well.

Market Segmentation

The publisher's global shingles vaccine market 2020-2024 is segmented as below:

Type:
  • Recombinant Vaccines
  • Live-attenuated Vaccines
Geographic Segmentation:
  • North America
  • Europe
  • Asia
  • ROW
Key Trends for global shingles vaccine market 2020-2024 growth

This study identifies high incidence and prevalence of shingles as the prime reasons driving the global shingles vaccine market 2020-2024 growth during the next few years.

Prominent vendors in global shingles vaccine Market 2020-2024.

The publisher provides a detailed analysis of around 25 vendors operating in the global shingles vaccine market 2020-2024, including some of the vendors such as CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience and Vaccitech Ltd. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CanSino Biologics Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • SK Bioscience
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type placement
  • Recombinant vaccines - Market size and forecast 2019-2024
  • Live-attenuated vaccines - Market size and forecast 2019-2024
  • Market opportunity by Type
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • CanSino Biologics, Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • SK Bioscience
  • Vaccitech Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ million)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Type placement - Market share 2019-2024 (%)
23. Comparison by Type placement
24. Recombinant vaccines - Market size and forecast 2019-2024 ($ million)
25. Recombinant vaccines - Year-over-year growth 2019-2024 (%)
26. Live-attenuated vaccines - Market size and forecast 2019-2024 ($ million)
27. Live-attenuated vaccines - Year-over-year growth 2019-2024 (%)
28. Market opportunity by Type
29. Customer landscape
30. Market share by geography 2019-2024 (%)
31. Geographic comparison
32. North America - Market size and forecast 2019-2024 ($ million)
33. North America - Year-over-year growth 2019-2024 (%)
34. Europe - Market size and forecast 2019-2024 ($ million)
35. Europe - Year-over-year growth 2019-2024 (%)
36. Asia - Market size and forecast 2019-2024 ($ million)
37. Asia - Year-over-year growth 2019-2024 (%)
38. ROW - Market size and forecast 2019-2024 ($ million)
39. ROW - Year-over-year growth 2019-2024 (%)
40. Key leading countries
41. Market opportunity by geography ($ million)
42. Impact of drivers and challenges
43. Vendor landscape
44. Landscape disruption
45. Industry risks
46. Vendors covered
47. Market positioning of vendors
48. CanSino Biologics Inc. - Overview
49. CanSino Biologics Inc. - Product and service
50. CanSino Biologics Inc. - Key offerings
51. CanSino Biologics Inc. - Key customers
52. CanSino Biologics Inc. - Segment focus
53. Curevo Inc. - Overview
54. Curevo Inc. - Product and service
55. Curevo Inc. - Key offerings
56. Curevo Inc. - Key customers
57. Curevo Inc. - Segment focus
58. GeneOne Life Science Inc. - Overview
59. GeneOne Life Science Inc. - Product and service
60. GeneOne Life Science Inc. - Key offerings
61. GeneOne Life Science Inc. - Key customers
62. GeneOne Life Science Inc. - Segment focus
63. GlaxoSmithKline Plc - Overview
64. GlaxoSmithKline Plc - Business segments
65. GlaxoSmithKline Plc - Key offerings
66. GlaxoSmithKline Plc - Key customers
67. GlaxoSmithKline Plc - Segment focus
68. Merck & Co. Inc. - Overview
69. Merck & Co. Inc. - Business segments
70. Merck & Co. Inc. - Key offerings
71. Merck & Co. Inc. - Key customers
72. Merck & Co. Inc. - Segment focus
73. SK Bioscience - Overview
74. SK Bioscience - Product and service
75. SK Bioscience - Key offerings
76. SK Bioscience - Key customers
77. SK Bioscience - Segment focus
78. Vaccitech Ltd. - Overview
79. Vaccitech Ltd. - Product and service
80. Vaccitech Ltd. - Key offerings
81. Vaccitech Ltd. - Key customers
82. Vaccitech Ltd. - Segment focus
83. Currency conversion rates for US$
84. Research Methodology
85. Validation techniques employed for market sizing
86. Information sources
87. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • CanSino Biologics Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • SK Bioscience
  • MORE
The publisher Announces the Publication of its Research Report-Global Shingles Vaccine Market 2020-2024.

The publisher recognizes the following companies as the key players in the global shingles vaccine market: CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience and Vaccitech Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the high incidence and prevalence of shingles."

According to the report, one of the major drivers for this market is the approval of shingles vaccines and favorable reimbursement policies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • CanSino Biologics Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • SK Bioscience
  • Vaccitech Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll